MicroPort CardioFlow Medtech Corporation (MROPF)
- Previous Close
0.0000 - Open
0.1293 - Bid 0.0575 x --
- Ask 0.1375 x --
- Day's Range
0.1293 - 0.1293 - 52 Week Range
0.1293 - 0.3300 - Volume
100 - Avg. Volume
1 - Market Cap (intraday)
307.55M - Beta (5Y Monthly) 0.38
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Aug 28, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, Angelguide tip-preshaped super sti?ff guidewire, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company also provides technical consultation and technical services for medical devices clinical trial. MicroPort CardioFlow Medtech Corporation was founded in 2010 and is headquartered in Shanghai, China.
www.cardioflowmedtech.comRecent News: MROPF
View MorePerformance Overview: MROPF
Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MROPF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MROPF
View MoreValuation Measures
Market Cap
229.57M
Enterprise Value
22.99M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.67
Price/Book (mrq)
1.01
Enterprise Value/Revenue
0.43
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-91.04%
Return on Assets (ttm)
-6.71%
Return on Equity (ttm)
-14.41%
Revenue (ttm)
382.91M
Net Income Avi to Common (ttm)
-348.59M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
1.56B
Total Debt/Equity (mrq)
4.05%
Levered Free Cash Flow (ttm)
789.63M